Scott Wolchko

Professional, Unknown Company
San Diego, California,United States
Find Scott Wolchko's Email
Find Scott Wolchko's Phone

Who Is Scott Wolchko?

Total Experience31 years
CompanyUnknown Company
CountryUnited States

Scott Wolchko is the President, Chief Executive Officer, and a co-founder of Fate Therapeutics, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. Since co-founding the company in 2007, he has been instrumental in guiding its strategic direction and growth, establishing it as a leader in the development of universal, off-the-shelf cell products derived from induced pluripotent stem cells (iPSCs). Prior to Fate Therapeutics, he held key roles in business development and finance at Halozyme Therapeutics and began his career in the investment banking sector, focusing on life sciences. His leadership has been pivotal in advancing novel cell therapies into the clinic and securing major strategic collaborations.

Scott Wolchko LinkedIn page

How Did Scott Wolchko's Career Path Shape Their Journey?

Scott Wolchko's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Fate Therapeutics, Inc. - Founder and President, CEO & CFO(2006 to 2024)
Bocada, Inc. - Chief Financial Officer(2001 to 2006)
drugstore.com - Senior Director - Corporate Development(1999 to 2001)
Morgan Stanley & Co. - Associate / Analyst - Investment Banking(1994 to 1999)

What Are Scott Wolchko's Key Achievements?

Co-founder and CEO of Fate Therapeutics

Co-founded Fate Therapeutics in 2007 and has successfully led the company as President and CEO, transforming it from a startup into a prominent, publicly traded biopharmaceutical company at the forefront of cellular medicine.

Pioneer in iPSC-derived Cell Therapy

Under his leadership, Fate Therapeutics pioneered the clinical development of immunotherapies derived from induced pluripotent stem cells (iPSCs), advancing the first-ever iPSC-derived NK cell and T-cell product candidates into clinical trials.

Secured Major Strategic Collaborations

Orchestrated multi-billion dollar strategic collaborations with major pharmaceutical companies, including Janssen and Ono Pharmaceutical, to develop and commercialize iPSC-derived cell therapies, validating the company's platform and providing significant non-dilutive funding.

Led Successful IPO

Guided Fate Therapeutics through its successful Initial Public Offering (IPO) on the NASDAQ in 2013, raising essential capital to fund its innovative research and development pipeline.

What's Scott Wolchko's Educational Background?

M.S., BioChemical Engineering

University of Virginia - Year 1992

B.S., BioMedical Engineering

University of Vermont - Year 1988

Buying Intent Signals for Scott Wolchko

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Unknown Company
Total employeesUnknown
HeadquartersUnknown
FoundedUnknown

Represents a placeholder for a non-existent or undefined company. In data and programming, 'null' signifies the intentional absence of any object value.

Unknown Company Funding Information
Unknown - Total Funding Raised
not applicable - Most recent funding amount
not applicable - Number of funding rounds
not applicable - Latest funding round

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Intent Signals

Buyer intent signals

CRM Enrichment

Contact Enrichment

Workflows and tasks

Workflows and tasks

Integrations

Integrations

Thousands of companies, including, are just a search away.